Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.66 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3607843 | 1.00 | SLC6A4 (0.66) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| Hydrochloric Acid SCHEMBL28265941 | 0.98 | SLC6A4 (0.64) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| Hydrochloric Acid SCHEMBL11158645 | 0.98 | SLC6A4 (0.64) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL28868211 | 0.92 | SLC6A4 (0.56) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| SCHEMBL3788967 | 0.91 | SLC7A5 (0.55) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| SCHEMBL1744966 | 0.91 | SLC7A5 (0.55) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| Hydrochloric Acid SCHEMBL27577123 | 0.90 | SLC6A4 (0.54) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| Hydrochloric Acid SCHEMBL27577124 | 0.90 | SLC6A4 (0.54) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| SCHEMBL28567121 | 0.88 | SLC6A4 (0.66) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 | |
| SCHEMBL10888091 | 0.87 | SLC6A4 (0.51) | SLC6A4TAAR1SLC6A2SLC6A3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110655500-B | Carbamate derivatives, preparation method and application thereof | 浙江京新药业股份有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-110655500-A | Carbamate derivatives, preparation method and application thereof | 浙江京新药业股份有限公司 | 2020-01-07 | — | — | CN | claimed |
| US-6232305-B1 | ANTICANCER AGENTS; BONE DISORDERS; ANTIARTHRITIC AGENTS; RESPIRATORY SYSTEM DISORDERS | NAEJA PHARMACEUTICAL INC. (CA) | 2001-05-15 | — | — | US | claimed |
| EP-0950046-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (CA) | 1999-10-20 | — | — | EP | claimed |
| WO-1998012176-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (US) | 1998-03-26 | — | — | WO | claimed |
| JP-62289194-A | — | — | None | — | — | JP | disclosed |
| EP-4731211-A1 | ALLYL- AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Definium Therapeutics US, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250312309-A1 | ALLYL-AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Mind Medicine, Inc. (US) | 2025-10-09 | — | — | US | disclosed |
| WO-2024263978-A1 | ALLYL- AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Mind Medicine, Inc. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-10864253-B2 | Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage | ARAIM PHARMACEUTICALS, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| CN-110655500-B | Carbamate derivatives, preparation method and application thereof | 浙江京新药业股份有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-110655500-A | Carbamate derivatives, preparation method and application thereof | 浙江京新药业股份有限公司 | 2020-01-07 | — | — | CN | disclosed |
| US-4562263-A | HYPOTENSIVE AND HYDERTENSIVE AGENTS, ANTIDEPRESSANTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-12-31 | — | — | US | disclosed |
| EP-0084928-B1 | PROCESS FOR PRODUCING THREO-3-(3,4-DIHYDROXYPHENYL)SERINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-11 | — | — | EP | disclosed |
| EP-0128684-A1 | Process for producing 3-(3,4-dihydroxyphenyl) serine | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1984-12-19 | — | — | EP | disclosed |
| US-4480109-A | Process for producing threo-3-(3,4-dihydroxyphenyl)serine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-10-30 | — | — | US | disclosed |
| EP-0084928-A1 | Process for producing threo-3-(3,4-dihydroxyphenyl)serine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-08-03 | — | — | EP | disclosed |
| US-4020060-A | ANTIBACTERIAL, ANTIBIOTICS | RICHARDSON-MERRELL INC. (US) | 1977-04-26 | — | — | US | disclosed |
| US-4016037-A | FERMENTING A HYDANTOIN COMPOUND WITH FLAVOBACTERIUM AMINOGENES OR ITS ENZYMES | AJINOMOTO CO., INC. (JA) | 1977-04-05 | — | — | US | disclosed |
| US-3994877-A | 6-[α-AMINO-ω-(3,4-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES | RICHARDSON-MERRELL INC. (US) | 1976-11-30 | — | — | US | disclosed |